IO Biotech (IOBT) entered into a loan facility of up to EUR 57.5M from the European Investment Bank. The debt facility includes three committed tranches totaling up to EUR 37.5M, which will become available if the company satisfies certain conditions, and one uncommitted accordion tranche of EUR 20M. The company expects the first two tranches to be available for disbursement in the first quarter of 2025.
Education
About Us
Working with TipRanks
Follow Us
1